Most Recent
Generic drug maker Sun Pharma has succeeded in invalidating Otsuka Pharmaceutical’s patent for an injectable, controlled release form of the Japanese drug maker's top-selling antipsychotic Abilify.
Construction PRO
Real estate fund manager Charter Hall has paid $47 million to purchase a Clinipath Pathology lab in Perth, bolstering its social infrastructure investment trust.
A nurses union has won orders barring St Vincent's Private from representing to nurses that protected industrial action in relation to the closure of beds at various hospitals is unlawful and unprotected.
Legal fees will eat up more than half of a $3.5 million settlement reached in a class action over deaths at a NSW aged care facility during the COVID-19 pandemic.
Pharmaceutical giant Novartis is challenging the loss of its case against Sydney-based generics company Pharmacor over a patent for heart medication Entresto.
Global law firm K&L Gates has hired former Corrs Chambers Westgarth IP litigator Rachelle Downie as a partner in its Melbourne office.
Law firm Gordon Legal has filed a tenth class action on behalf of junior doctors in Victoria who were allegedly underpaid for shift work, after several landmark wins in similar cases.
A class action against implant maker Exactech has been stayed in light of its US bankruptcy, but a carve out allows the firm that brought the case to continue settlement negotiations.
US drug maker Pfizer is facing a class action investigation into the possible link between its injectable contraceptive Depo-Provera and brain tumors.
Women who were allegedly injured by defective pelvic mesh implants can apply to set aside two approved settlements against Johnson & Johnson and Boston Scientific worth $405 million.